REGN
Regeneron Pharmaceuticals, Inc.Healthcare$761.85
▲ Bullish
Mkt Cap: $80.54B|Float: 98.6M|SI: 2.5%|DTC: 4.0
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
26.0%
52W Range
$475-$820
ATR(14)
$19.40
Exp. Move
±2.2%
P/C Ratio
0.96
Earnings
Apr 29
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Moderate
REGN Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $1.0M
- Max Pain
- $745.00
- Expected Move
- ±2.2%
- Put/Call OI
- 0.96
- Net Premium
- $3.7M
- Spot Price
- $761.85
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$17.00 | ±2.2% | $744.85 | $778.85 |
| 2026-04-17 | 15 | ±$49.30 | ±6.5% | $712.55 | $811.15 |
| 2026-04-24 | 22 | ±$33.40 | ±4.4% | $728.45 | $795.25 |
| 2026-05-01 | 29 | ±$43.55 | ±5.7% | $718.30 | $805.40 |
| 2026-05-08 | 36 | ±$43.55 | ±5.7% | $718.30 | $805.40 |
| 2026-05-15 | 43 | ±$98.35 | ±12.9% | $663.50 | $860.20 |
Explore REGN options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.